LPOXY Therapeutics, Inc.

About LPOXY Therapeutics, Inc.

LPOXY Therapeutics is a clinical-stage company focused on developing therapies to heal intestinal diseases using oxygen. Their mission is to protect people from antibiotic-induced C. difficile colitis superinfections and to help those suffering from inflammatory bowel diseases through innovative oxygen-based treatments.

Products & Services

SIDIPREV™:An orally-administered, metered-dose intestinal oxygen delivery system being developed for multiple indications, including prevention of antibiotic-induced C. difficile colitis, treatment of inflammatory bowel diseases (Crohn's and Ulcerative Colitis), and addressing Multiple Sclerosis via oxygen's effectiveness against epsilon-toxin-producing C. perfringens.

Specialties

Enteric Aerobization Therapy Intestinal Oxygen Delivery C. difficile Colitis Prevention Inflammatory Bowel Diseases Treatment Multiple Sclerosis Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 28000000 MR: - FA: 28 million FAN: 28000000	D: 2025-09-03 FD: 2025-09-03	1 investors

Series A Latest

2025-09-03

$28.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Larry D. Sutton

Physician-Scientist and Prolific Entrepreneur

P

Porter W. Anderson

M

Marc Gurwith

Chief Medical Officer

S

Sophia Yu

Chief Operating Officer

M

Michael Gross

World-Renowned Mass Spectrometrist

C

Carmen Betancourt-Riche

EVP Regulatory Affairs

View 5 more team members with Pro

Unlock Full Team Directory

Recent News